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1. Introduction 
Approximately one third of the human population is infected with Mycobacterium 
tuberculosis (Mtb). Most individuals establish latent infection. In approximately 10% of 
infected individuals active disease develops (Raviglione, 2003). It is accepted that the 
outcome of infection largely depends on the peculiarities of host immune reactivity that are 
controlled genetically.  
A lot of efforts have been made to elucidate immune mechanisms of TB defense. The studies 
have identified immune cells, molecules and pathways essential for TB protection. It has 
been demonstrated that protection depends primarily on the activity of Th1 lymphocytes 
and macrophages (Schluger & Rom, 1998; Flynn & Chan, 2001; Boom et al., 2003; North & 
Jung, 2004; Kaufmann, 2006). Th1 cells produce immune mediators, such as IFN- and TNF-
 that activate macrophages. Activated macrophages produce bactericidal molecules (e.g., 
reactive nitrogen and oxygen species) that kill mycobacteria. Both macrophages and T cells 
secrete a wide range of soluble factors that promote migration of other immune cells to the 
site of infection. At the site, immune cells settle to form granuloma that prevents 
mycobacteria dissemination. Overall, immune protection depends on efficient pathogen 
killing (i.e., antibacterial response) and efficient concentration of immune cells at the site of 
infection (i.e., inflammatory response). Multiple studies have demonstrated that deficiency 
in cells and molecules implicated in either of these responses results in extremely severe TB, 
supporting a concept that TB develops as a result of immune deficiency. On the other hand, 
since Koch’s studies, TB has been considered as an immunopathological disease. In this 
concept, disease develops due to uncontrolled inflammatory reactivity of the host to the 
pathogen. Direct evidences for this concept had not been available, but are now 
accumulating, raising a general question on the role for immune deficiency and 
hyperreactivity in the pathogenesis of tuberculosis.  
As noted above, the outcomes of Mtb infection are very diverse. The diversity consists not 
only in the establishment of latent infection vs progression to active disease, but also in a 
great variability in the manifestations of active disease. These manifestations differ by the 
type and the extent of lung tissue pathology, clinical disease characteristics, the rate of 
disease progression, and patient’s responsiveness to treatment. Immune mechanisms 
operating during the onset of Mtb infection and during active disease differ. In particular, 
www.intechopen.com
 
Understanding Tuberculosis – Analyzing the Origin of Mycobacterium Tuberculosis Pathogenicity 
 
20
inflammatory response is prerequisite for efficient control of Mtb at initial stages of the 
infection, but may become deleterious at chronic stage of disease. While mechanisms of 
initial TB control have been studied extensively, pathogenesis of TB progression is much 
less understood.  
This review summarizes recent studies on TB immunopathogenesis focusing on the role for 
host inflammatory response in TB progression. 
2. Mtb infection and host immune response in the lungs  
2.1 Cellular immune responses to Mtb infection 
Before considering processes ongoing during TB progression, it is important to summarize 
current view of the onset of pulmonary Mtb infection.  
Mycobacteria enter the lungs trough the respiratory tract. Following the inhalation, the 
bacilli are phagocytosed by alveolar macrophages (AM) and airway dendritic cells (DC). 
Infected cells migrate to distal sites of the lung and undergo necrosis allowing Mtb to enter 
parenchyma and infect parenchymal phagocytes. Pattern recognition receptors (PRRs) 
expressed by macrophages, DC and epithelial cells (both on the surface and within the cell) 
interact with Mtb ligands (reviewed in detail in Kleinnijenhuis et al., 2001; van Crevel et al., 
2002; Dorhoi et  al., 2011; Sasindran & Torrelles, 2011). The interaction drives host cells to 
enhance the expression of adhesion molecules and produce inflammatory cytokines and 
chemokines that recruit new immune cells (i.e., neutrophils, monocytes, lymphocytes) to the 
infectious focus. The accumulating cells initiate formation of granuloma (reviewed in detail 
in van Crevel et al., 2002; Russel et al., 2009; Flynn et al., 2011). 
Infected DC assisted by neutrophils (Abadie et al., 2005; Blomgran & Ernst,  2011) migrate to 
the lymph nodes and initiate T cell response. Due to a high production of IL-12, the response 
is largely polarized towards a Th1 type. Th1 cells generated in the lymph nodes migrate to 
the site of mycobacterial infection.  
At the site, effector Th1 cells undergo functional maturation (Kapina et al., 2007) and 
increase their production of chemokines and effector cytokines. Chemokines attract new 
immune cells, amplifying local inflammatory DTH-type reaction and promoting 
granuloma formation. The cytokines IFN- and TNF- activate adjacent macrophages 
(Schluger & Rom, 1998; Flynn & Chan, 2001; Pearl et al., 2001). Activated macrophages 
produce reactive nitrogen and oxygen intermediates (RNI, ROI), enhance surface 
expression of MHC class II molecules and increase secretion of inflammatory mediators, 
i.e. acquire ability to kill Mtb, enhance antigen presentation and propagate local 
inflammation and granuloma formation.  
Besides macrophages and CD4+ Th1 cells, other immune cells accumulate at the infectious 
focus. CD8+ T cells produce IFN- and may exhibit cytotoxic effect against Mtb-infected cells 
(Lalvani et al., 1998; Cooper, 2009); Th17 cells promote Th1 immunity and neutrophil 
recruitment (Khader & Cooper, 2008); granulocytes phagocyte mycobacteria,  mediate 
bactericidal effect, and contribute to granuloma formation (Korbel et al., 2008; Rivas-
Santiago et al., 2008); B lymphocytes together with T cells form follicular structures (so-
called “tertiary lymphoid tissues”) that orchestrate  immune response ongoing in the lungs 
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(Ulrichs et al., 2004). NK cells, unconventional T lymphocytes, regulatory T cells are also 
attracted (Cooper, 2009).  
Overall, TB protection is achieved by two major mechanisms: Mtb killing that, ideally, stops 
the infection, and formation of granulomas that prevents Mtb dissemination. Both processes 
depend upon proper functioning of sets of surface receptors and soluble factors that provide 
immune cell activation, migration and effector activity. Factors essential for the current 
review are briefly discussed below. 
2.2 Molecular mediators of immune response 
Innate immune cells recognize Mtb ligands by a set of PRRs that include Toll-like receptors 
(TLRs), C-lectin type receptors (CLRs), scavenger receptors (SRs),  immunoglobulin Fc 
receptors (FcRs), NOD-like receptors (NLRs)  (reviewed in detail in van Crevel et al., 2002; 
Sasindran & Torrelles, 2011; Dorhoi et al, 2011). Ligation of PRRs induces gene expression, 
primarily the expression of genes for early response cytokines IL-1, TNF-, IL-6.  All, IL-1, 
TNF- and IL-6 promote further activation of macrophages (Kishimoto, 2005). In addition, 
IL-1 is highly chemotactic for T lymphocytes, stimulates CD4+ T cell proliferation and  
IFN- production, controls early processes of granuloma formation, and stimulates the 
generation and the recruitment of neutrophils (Hunninghake et al., 1987; Sugawara et al., 
2001; Miller et al., 2007;  Oliveira et al., 2008; Ueda et al., 2009). TNF- is critical for the 
continued organization of the granulomatous lesions (Kindler et al., 1989; Flynn et al., 1995; 
Bean et al., 1999; Roach et al., 2002) and has immunoregulatory propereties (Orme & 
Cooper, 1999; Motoo et al, 2009).  IL-6 modulates T- cell response, is essential for antibody 
formation, and stimulates hematopoiesis, in particularly, the myeloid lineage (Liu et al, 
1997; Kishimoto, 2005; Walker et al., 2008). All three cytokines may cause severe pathology. 
They have been implicated in microvascular thrombosis, capillary leak and neutrophilic 
chemotaxis, produce organ dysfunction, systemic inflammation, acute-phase response, 
cachexia and fever (Tracey et al., 1987; Hernandez-Pando et al., 1994; Chang &  Bistrian, 
1998; Bekker et al., 2000; Agriles et al., 2005; Oliveira et al., 2008).  
Chemokines are secreted by macrophages, neutrophils, T lymphocytes, endothelial cells and 
other local cells.  CC chemokines CCL2, CCL3, CCL4, CCL5, and other attract monocytes, 
lymphocytes, macrophages, DC, NK cells to the site of infection and favor Th1 response. 
CXC chemokines CXCL10 (IP-10) and CXCL9 (MIG) are produced in response to IFN- and 
attract predominantly T-lymphocytes and monocytes, propagating T cell response. CXC 
chemokines CXCL8 (IL-8), CXCL2 (MIP-2) and CXCL1 (KC) are mainly chemotactic for 
hematopoietic stem cells and granulocytes and are responsible for neutrophilic 
inflammation at advanced stages of TB (Rhoades et al., 1995; Sasindran & Torrelles, 2011).   
A separate set of molecules mediate Mtb killing. IFN- activates macrophage for Mtb killing. 
Granzymes and perforin mediate cytotoxicity of CD8+ T cells and NK cells. ROI and RNI, 
defensins, cathelicidin, proteases and other bactericidal molecules produced by IFN--
activated macrophages and by neutrophils mediate Mtb killing (Flynn & Chan, 2001; van 
Crevel et al., 2002;  Rivas-Santiago et al., 2008). Of note, these molecules are released not 
only intracellularly but also extracellularly. Thus, extracellular milieu at the focus of the 
infection becomes highly inflammatory containing multiple mediators that are not present 
in healthy lungs and that potentially are highly deleterious. During active TB, cytokines, 
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chemokines and other mediators released by immune cells, as well as activated immune 
cells themselves, are found not only at the focus of the infection, but also in the 
bronchoalveolar fluid (BAL) and in the circulation where they may mediate systemic 
inflammatory response. 
2.3 Granuloma in TB protection and pathology 
It is generally assumed that formation of granuloma represents a host strategy to contain the 
infection and limit pathogen dissemination. However, granulomatous response is observed 
not only in individuals with latent infection, but also in TB patients, including patients with 
extremely severe and rapidly progressing TB. Thus, it was suggested that a mere formation 
of granuloma is not enough to prevent TB, rather it is important how “proper” granuloma is 
functioning (Flynn et al., 2011).  
In humans, granulomas observed during latent infection (“tuberculomas”) are usually 
small, compact, solid and not numerous. They consist of macrophages and lymphocytes and 
a small amount of neutrophils. A central core contains epithelioid macrophages and a few 
neutrophils and multinucleated giant cells (Lin et al., 2009). The wall is well organized and 
contains follicle-like structures, in which proliferating lymphocytes reside (Ulrichs & 
Kaufmann, 2006). It is believed that such granulomas are able to control the infection and 
keep Mtb in a dormant state (Flynn et al., 2011).  
During active disease, the granuloma cannot contain the infection. Immune cells continue to 
arrive, the granuloma grows and its organized structure disrupts (Ulrichs & Kaufmann, 
2006; Russel et al., 2009; Cardona et al., 2011). Macrophages differentiate into epithelioid 
cells. The neutrophil influx increases and the centrum of the granuloma necrotizes and then 
caseates resulting in the formation of necrotizing and caseating granulomas. In necrotizing 
granulomas the central area consists mainly of degenerating neutrophils; in caseating 
granulomas it is presented by cell debris.  The centrum is surrounded by a dense zone of 
epithelioid macrophages, multinucleated giant cells and lymphocytes (Lin et al., 2009). 
Eventually, the centrum caseous breaks into the bronchus, releasing bacteria into the 
respiratory tract and resulting in the formation of cavities. Mtb replication goes out of 
control. It has long been thought that the caseum represents a nutritional site for rapid Mtb 
replication. However, recent data have shown that: (i) many necrotic areas are devoid of 
Mtb (Ulrichs & Kaufmann, 2006), (ii) microbes located in the caseum resemble stationary-
phase organisms, whereas replicating Mtb are found in sputum and BAL, and in connection 
with neutrophils (Eum et al., 2010). It is therefore suggested that Mtb replication does not 
occur in the liquefying cavity, but rather starts upon the exit of the bacilli from that cavity 
into the sputum.  
Many questions regarding the functioning of granulomas remain unclear. What is an 
association between caseation and TB activity? Caseation is often considered as a hallmark 
of active disease. However, it has been reported that in non-human primates caseation 
occurs very early in granuloma formation, shortly after macrophages in the lungs become 
infected, i.e. during the very early, latent stage of the infection. In this model, caseating 
granuloma could successfully contain the pathogen and did not necessarily proceed to 
active TB (Lin et al., 2006), suggesting that it is probably the extent of caseation, but not the 
caseation itself that determines disease activity.  Next, caseous (tuberculous) pneumonia is 
www.intechopen.com
 
Inflammation and Immunopathogenesis of Tuberculosis Progression 
 
23 
an example of active TB disease that is not accompanied by the formation of classical 
granulomas. In this disease, extensive areas of parenchymal infiltration with multiple 
necrotizing and caseating foci are observed, but these foci are not structured, instead they 
extend contiguously in the lung parenchyma. Clinical manifestations of caseous pneumonia 
are extremely severe with evident signs of severe systemic inflammation; but exact 
pathways underlying the development of caseous pneumonia (vs caseating granulomas) are 
poorly understood. Another important question is whether caseation (either during 
pneumonia or in granulomas) represents host response to unlimited Mtb growth (i.e., is a 
result of inefficient Mtb control) or whether it is a result of “improper” host reactivity to a 
relatively small number of dormant Mtb persisting in early or mature granulomas. Several 
recent reviews have discussed these questions and suggested hypotheses to explain the 
development of active TB in non-immunosuppressed patients (Russel, 2009; Cardona, 2009; 
2010; Flynn et al., 2011). 
3. TB infection in hosts with immune deficiency   
A role for immune deficiency in the pathogenesis of Mtb infection has been addressed in 
multiple studies.  
In mice, targeted mutations of PRR genes impaired host resistance to Mtb (Drennan et al., 
2004; Divangahi et al., 2008; Mayer-Barber et al., 2010). Deficiency on PRR adaptor 
molecules, e.g., MyD88, CARD9, TIR8, resulted in extremely high susceptibility (Garlanda et 
al., 2007; Dorhoi et al., 210; Mayer-Barber et al., 2010). Lack of “early response cytokines” 
(i.e., IL-1, TNF-, IL-6) or their receptors impaired granuloma formation, cytokine and 
chemokine synthesis and rendered mice extremely susceptible to Mtb infection. (Ladel et al., 
1997; Bean et al., 1999; Juffermans et al., 2000;  Yamada et al., 2000;  Roach et al., 2002; 
Fremond et al., 2007).  
Defects in acquired immunity also led to disease exacerbation. Mice deficient in T cells, 
(especially, in CD4+ subset) and Th1 type cytokines (i.e., IL-12p40, IFN-) succumbed early 
to Mtb infection with high bacterial loads (Cooper et al., 1993; Flynn et al., 1993; 1995; 
Cooper et al., 1997; Mogues et al., 2001). Similar effects were observed in mice with defects 
in enzymes involved in the generation of host bactericidal molecules (e.g., iNOS, p47phox 
(MacMicking et al., 1997; Cooper et al., 2000; Scanga et al., 2001; Jung et al., 2002). 
Observations in humans are in line with results obtained in mice. A role for TNF- in host 
defense is supported by reactivation of TB in rheumatoid arthritis patients receiving anti-
TNF therapy (Keane et al., 2001). An essential role for CD4+ T cells in anti-TB defense is 
evident from a high incidence of TB and altered histopathological characteristics of TB (i.e., 
diffuse necrotic lesions instead of structured granulomas) in humans co-infected with 
immunodeficiency virus (Chaisson et al, 1987). Finally, humans with mutations in molecules 
involved in Th1 immunity, i.e., the IL-12p40 subunit, the IL-12 receptor 1 chain, the IFN--
receptor ligand binding chain, STAT1, exhibit high susceptibility to mycobacterial infections 
induced by Mtb, BCG or environmental mycobacteria (Altare et al., 1998; Dorman et al., 
2000; Casanova & Abel, 2002).  
Altogether, multiple studies have associated severe Mtb infection with immune deficiency 
and poor control of pathogen growth. This association explains why hosts with genetic or 
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acquired immune deficiencies suffer from severe mycobacterial infections. However, it 
cannot explain why active TB occurs in immunologically-competent hosts, or why TB 
exhibits so many different clinical manifestations.  
4. Inflammation and TB progression 
Inflammation always accompanies infection and represents a critical component of host 
immune defense. However, inflammatory reactions may also be deleterious and promote 
disease exacerbation. The first indication of a damaging role of host immune response 
during TB was obtained by Koch who described local and systemic reactions and disease 
worsening following treatment of TB patients with Mtb extract (Koch, 1890, as cited in 
Moreira et al., 2002). Thereafter, multiple observations have associated severe TB course 
with high inflammatory reactions. However, it is usually very difficult to dissect whether 
severe inflammation is a cause or a result of disease severity, i.e., whether it develops due to 
intrinsic host hyperreactivity to the pathogen or whether it mirrors high pathogen load (i.e. 
deficient Mtb control). Gene targeting approach is not very helpful with this respect as the 
majority of factors mediating inflammation are prerequisite for the development of 
protection and therefore their targeting or neutralization results in disease exacerbation and 
masks potential pathological properties. Yet, several experimental settings made this 
dissection possible. Detailed analysis of theses studies allows identifying immunological 
features critical for TB progression.  
4.1 Mtb infection in mice with deficiency in negative regulators of inflammation 
Several studies examined the course of TB in mice with deficiency in negative regulators of 
inflammation. TIR-8 (Toll/IL-1R), a member of the IL-1R family, is an inhibitor of 
inflammation. The receptor functions by trapping of TNFR-associated factor 6 and IL-1R 
associated kinase 1 and inhibiting activation of NF-kB induced by members of the IL-1/TLR 
family (Polentarutti et al., 2003; Garlanda et al., 2007). In Mtb infected Tir-8-/- mice control of 
mycobacteria growth and T cell responses were unimpaired. Nevertheless, the mice were 
rapidly killed by low doses of Mtb. The disease was characterized by overwhelming 
inflammatory response in the lungs that manifested as increased production of IL-1 and 
TNF- and increased lung infiltration with neutrophils and macrophages. Blocking IL-1 
and TNF- with a mix of anti-cytokine antibodies significantly prolonged survival of Tir-8-/- 
mice supporting that their exaggerated mortality was associated with exacerbated 
inflammation and tissue damage (Garlanda et al., 2007). 
Similarly, mice lacking D6, a decoy and scavenger receptor for inflammatory CC 
chemokines, had normal control of bacteria replication but responded to Mtb infection by 
uncontrolled systemic inflammation and died from a fatal infection (Di Liberto et al., 2005).  
WSX-1, a component of IL-27R complex, is another molecule that plays a regulatory role 
during Mtb infection, mainly by dampening Th1 response. In the absence of WSX-1, Mtb 
infection induced elevated production of the pro-inflammatory cytokines TNF- and IL-
12p40. This led to concomitant activation of CD4 T cells, increase in IFN- production and 
macrophage effector functions. Bacterial loads were reduced, but mortality was accelerated, 
which was attributed to chronic hyperinflammatory response (Holscher et al., 2005).  
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4.2 Mtb infection in mice with deficiency in positive regulators of inflammation  
As discussed above, deficiency in molecules mediating inflammatory signals alters host 
control of Mtb replication and exacerbates Mtb infection. Strikingly, even when 
inflammatory pathways are altered, fatal infection is accompanied by overwhelming 
inflammation, supporting a concept that TB progression and lethality are associated with 
hyperinflammatory reactions.  
Dorhoi and coauthors (Dorhoi et al., 2010) examined Mtb infection in mice that lack CARD9, 
an adaptor molecule that collects signals from several PRRs. Mice developed a lethal 
infection accompanied by uncontrolled Mtb replication, by besides that – by a severe 
neutrophilic inflammation of the lung tissue and overproduction of factors involved in 
granulocyte generation and chemoattraction (i.e., G-CSF, KC). Neutralization of G-CSF or 
depletion of neutrophils reduced lung inflammation and prolonged host survival without 
affecting bacterial burdens. Thus, dampening neutrophilic inflammation at advanced stage 
of disease was enough to decrease disease severity. 
Mice with a deficiency in IL-1R developed lethal infection characterized by extremely high 
numbers of Mtb in their lungs. Of note, a characteristic feature of lethal infection was an 
elevated (but not a deficient) production of major proinflammatory cytokines, e.g., IL-1,  
IL-6, TNF- (Fremond et al., 2007).  
Mice deficient in TNF- or TNF- receptor developed extremely severe disease due to 
defects in granuloma formation (Bean et al.,1999). Of note, a characteristic feature of this 
infection was a prominent infiltration of the lung tissue with neutrophils.  
In humans, S180L polymorphism in TIRAP gene implicated in the TLR2- and TLR4-
mediated signaling, leads to the attenuation of inflammation and decreases the risk of TB 
development (Castiblanco et al., 2008).  
4.3 Anti-inflammatory treatment improves TB outcome  
Several groups examined the possibility to improve TB outcome by limiting immune 
inflammation. In patients with pulmonary TB, treatment with adjunctive corticosteroid 
therapy together with antibiotics accelerated sputum culture conversion in comparison with 
patients who received antibiotic treatment alone (Bilaceroglu et al., 1999). Adjunctive 
treatment with etanercept, a soluble TNF-receptor, reduced time to sputum culture 
conversion and improved clinical signs of TB in HIV infected patients (Wallis et al., 2004). 
Thalidomide, an inhibitor of TNF- production, improved treatment outcome in patients 
with pulmonary TB (Tramontano et al., 1995; Coral et al., 1996). Recently, an inhibitory 
effect of CC-3052, an inhibitor of phosphodiesterase-4, on TNF- production was shown. 
Co-treatment of Mtb infected rabbits and mice with isoniazid plus CC-3052 significantly 
reduced the level of TNF- expression and the extent of disease (Koo et al., 2011; Subbian et 
al., 2011). As mentioned above, simultaneous blocking of IL-1 and TNF- significantly 
prolonged survival of Tir-8-/- mice, and neutralization of G-CSF or depletion of neutrophils 
decreased disease severity in CARD9-/- mice (Garlanda et al., 2007; Dorhoi et al., 2010). In 
contrast to anti-TNF treatment, treatment of mice with TNF- or BCG expressing TNF- 
significantly increased lung tissue inflammation and resulted in accelerated mortality 
without affecting the bacillary load (Moreira et al., 2002). Altogether, the studies show that 
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dampening immune inflammation during TB may significantly ameliorate disease outcome 
without affecting Mtb replication.  
4.4 Mtb infection in hosts with genetic differences in the extent of inflammation 
Studies reviewed above are largely based on the analysis of TB infection in hosts with 
artificially altered or modulated immune responses. Such interventions may interfere with 
processes naturally operating in the infected host. To elucidate whether the extent of 
inflammation affects TB progression in a “normal” population, several groups have 
compared immune responses in mice genetically resistant and susceptible to TB. In different 
models, susceptible mice produced more proinflammatory cytokines and developed 
stronger neutrophilic inflammation than resistant mice (Cardona et al., 2003; Eruslanov et 
al., 2004; Eruslanov et al., 2005; Keller et al., 2006). To directly address an association 
between inflammatory reactions and TB progression, we have recently analyzed TB severity 
and immune reactivity in a panel of genetically heterogeneous (A/SnxI/St)F2 hybrid mice 
(Lyadova et al., 2010). The hybrids originated from TB-highly-susceptible I/St and more 
resistant A/Sn mice that following challenge with Mtb displayed different rates of TB 
progression (Lyadova et al., 2000; Sanchez et al., 2003; Eruslanov et al., 2004). In F2 mice, the 
rate of TB progression did not depend on lung Mtb loads or the levels of lung expression of 
iNOS, IFN-, IL-12, or CCL5, i.e. genes controlling antibacterial response. Instead, it directly 
correlated with high lung expression of inflammation-related factors, such as IL-1, IL-6, IL-
11, CXCL2, several metalloproteinases. Another characteristic feature of rapidly progressing 
TB was the accumulation in the infected lungs of Gr-1-positive cells (see below for details). 
Thus, similarly to gene-targeted mice, in F2 mice severe infection was characterized by: (i) 
overexpression of proinflammatory factors and (ii) excessive infiltration of the lung tissue 
with neutrophil-like cells. Further analysis suggested that these manifestations were a 
consequence of increased transcription of proinflammatory factors in host macrophages and 
were predetermined genetically (Lyadova et al., 2010).  
A role for host genetic factors in the control of inflammation and TB progression was 
directly demonstrated in the studies by Kramnik’s group (Pan et al., 2005; Yan et al., 2007). 
The authors identified sst1 genetic loci on mouse chromosome 1 that controls progression of 
pulmonary TB. Different susceptibility of sst1 congenic mice to Mtb infection was associated 
with neither Th1 cell activation nor with iNOS/NO responses but was due to different host 
capacity to mount necrotic lung inflammation and was mediated by macrophages. 
4.5 T lymphocytes in TB exacerbation  
T lymphocytes are responsible for efficient protection against mycobacteria. However, they 
may also contribute to TB exacerbation. A series of recent studies performed in programmed 
death-1 (PD-1) knockout mice has clearly demonstrated that (Lázár-Molnár et al., 2010; 
Barbar et al., 2011).  
PD-1 is an inhibitory receptor expressed on exhausting T cells; its engagement inhibits T cell 
proliferation and cytokine secretion. PD-1-deficient mice infected with Mtb developed 
unaltered or even increased CD4+ T cell and NO responses. Yet, they died because of severe 
infection characterized by uncontrolled bacterial proliferation, increased lung tissue 
pathology, neutrophilic infiltration, and high lung expression of proinflammatory cytokines 
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TNF-, IL-1, IL-6 and IL-17 (Lázár-Molnár et al., 2010; Barbar et al., 2011). Depletion of 
CD4+ T cells ameliorated TB course, indicating that CD4+ T cells themselves drove the 
increased bacterial loads and pathology seen in infected PD-1-deficient mice. In contrast to 
Mtb infection, resistance to viral infections was increased in PD-1 deficient mice (Velu et al., 
2009). Thus, in TB imbalanced T cell responses are more deleterious than during other 
infections.  
Our observations made in F2 model support the involvement of T cells in TB exacerbation 
(Lyadova et al., 2010). In this model, susceptible mice displayed first signs of TB progression 
(i.e., wasting) on day 16 post-challenge and died on days 26-35 post-challenge. Mice that had 
not succumbed to infection by the end of week 5 survived for as long as 140 days (the time 
of observation). It is well established that Mtb–specific Th1 response appears at week 2 and 
reaches its plateau at week 4 post-challenge. Thus, the most susceptible F2 mice succumbed 
to Mtb infection at a time when T cell response started to operate; mice that survived this 
period, lived for a long time. We believe that the onset (or a sudden increase, as in Koch’s 
studies) of T cell response represents a risk factor that may provoke disease exacerbation. 
The underlying mechanism likely involves T-cell dependent propagation of inflammation 
mediated by innate immune cells.  
The role for T cells in hyperinflammatory reactions and TB exacerbation is also supported 
by the immune restoration syndrome (IRS) observed in patients co-infected with HIV-1 and 
Mtb and initiating highly active antiretroviral therapy. The syndrome is characterized by the 
exacerbation of granulomatous lesions and massive inflammatory and Th1 cytokine storm. 
The syndrom has been associated with a sudden restoration of immune competence, i.e. an 
increase in the numbers of activated tuberculin-specific effector memory CD4 T cells 
(Autran et al., 2009).  
4.6 Infection induced by imp Mtb mutants 
Recently, several mutant Mtb strains bearing immunopathology (imp) phenotype have been 
generated. The mutants have unaltered capacity to grow and persist in mouse lungs, but 
induce poor inflammation and attenuated disease. TB-susceptible DBA/2 mice challenged 
with SigC mutant had decreased mortality associated with lower numbers of neutrophils 
and reduced levels of TNF-, IL-1, IL-6 and IFN- in their lungs (Khairul-Bariah et al., 
2008). Similar results were obtained when SCID mice were challenged with SigC mutant. 
whiB3 Mtb mutant induced milder disease than wild type Mtb strain due to reduced 
granulomatous inflammation in the lungs (Steyn et al., 2002 ). SigH Mtb mutant produced 
high bacterial counts in the lungs, but recruited fewer CD4+ and CD8+ T cells and was 
nonlethal in TB-susceptible C3H mice (Kaushal et al., 2002).  
Thus, peculiarities of infecting Mtb strain represent another factor that determines TB 
outcome by affecting inflammatory reactions.  
4.7 Inflammatory responses in patients with pulmonary TB 
In TB patients, severe infection is also associated with excessive inflammatory reactions. 
Patients with pulmonary TB have higher levels of proinflammatory cytokines IL-1, IL-6, 
TNF-, IL-8, and their inhibitors TNFRI, IL-1Ra and TGF- in sera and BAL fluid than 
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healthy controls and TB contacts (Zhang et al., 1995; Tsao et al., 1999; Tsao et al., 2000; 
Nemeth et al., 2011). Among TB patients, serum levels of TNF- and TGF- are significantly 
higher in patients with advanced TB compared to patients with mild-moderate TB (Fiorenza 
et al., 2005). In involved sites of TB, spontaneous release of IL-1, IL-6 and TNF- is 
significantly higher than in uninvolved sites and in miliary TB (Law et al., 1996). Patients 
with large TB cavity have much higher concentrations of TNF- and IL-1 than patients 
who have small or no cavity. Importantly, the ratios of TNF- to sTNF-RI and IL-1 to IL-
1RA in the BAL fluids are also higher in patients with large cavity. Thus, a role for the 
relative abundance of TNF- and IL-1 in tissue necrosis and cavity formation was 
suggested (Tsao et al., 2000).  
Besides high levels of proinflammatory factors, a characteristic feature of progressing 
pulmonary TB is high numbers of granulocytic cells in the BAL fluid (Law et al., 1996; Barry 
et al., 2008). It was demonstrated that in sputum and BAL fluids of patients with pulmonary 
TB neutrophils are more abundant and contain more intracellular bacilli than macrophages 
(Eum et al., 2010).   
In summary, hyperinflammatory reaction is a characteristic feature of progressing 
pulmonary TB in both humans and experimental animals. The reaction manifests as high 
expression of proinflammatory cytokines and prominent neutrophilic influx to the lung 
tissue. These manifestations develop irrespectively on exact pathways that have led to 
severe TB (e.g., defects in host capacity to control Mtb growth, host hyperreactivity to 
pathogen-derived signals, or peculiarities of infecting Mtb strain).  
Mechanisms whereby proinflammatory cytokines mediate their pathological activity have 
been studied during different pathological conditions and reviewed in detail elsewhere 
(Chang & Bistrian, 1998; Thacker, 2006;  Mootoo et al., 2009; Argiles et al., 2005). In contrast, 
data on the role for neutrophils in TB pathogenesis are contradictory and require special 
consideration. 
5. Neutrophils 
Physiological activities of neutrophils involve adhesion, migration to the site of 
inflammation, phagocytosis, degranulation, and release of inflammatory mediators. We will 
briefly review activities related to TB and discuss the controversial results of the studies that 
addressed the role of these cells in tuberculosis.  
5.1 Functional activities  
Neutrophils are among the first cells that arrive at the inflammatory focus (Appelberg & 
Silva, 1989). The process involves adhesion of circulating neutrophils to the endothelial cells 
and migration through the endothelial barrier and within the inflamed tissues. Neutrophils’ 
migration is driven by the inflammatory cytokines IL- and TNF-, the chemokines IL-8, 
CXCL2, CXCL1, bacteria products and molecules released by dying cells, i.e. it occurs in 
response to inflammation and tissue injury (reviewed in Witko-Sarsat et al., 2000).   
At the site of infection, neutrophils phagocytoze IgG- and complement-opsonized targets 
and exhibit bactericidal activity. The later is mediated by the production of ROI and release 
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of bactericidal molecules stored in neutrophils’ granules. ROI include: (i) superoxide anion 
and hydrogen peroxide generated by NADPH-dependent oxidase; (ii) hypochlorus acid and 
chloramines, generated by neutrophil-specific enzyme metalloperoxidase.  Granule-
associated bactericidal molecules are numerous and include short bactericidal peptides (e.g., 
human neutrophil peptides (HNPs) 1–3, cathelicidin LL-37, lipocalin 2); lactoferrin; serine 
proteases; metalloproteinases (Witko-Sarsat et al., 2000; Fu, 2003;  Martineau, et al. 2007; 
Rivas-Santiago et al., 2008). Macrophages utilize neutrophil bactericidal peptides to increase 
their antibacterial activity: they phagocyte apoptotic neutrophils and deploy neutrophils' 
bactericidal peptides to combat intracellular Mtb (Tan et al., 2006). 
An additional bactericidal mechanism is formation of extracellular traps (NETs) - a web of 
chromatin fibers that contain serine proteases and can trap and kill extracellular microbes 
(Brinkmann et al., 2004).  
Neutrophils are involved in the formation of granuloma (Seiler et al., 2003) and in the 
initiation of T cell response:  they were shown to transport live mycobacteria from 
peripheral tissues to the lymphoid organs and to deliver mycobacterial antigens to DC  in a 
form that makes DC more effective initiators of naïve CD4+ T cell activation (Abadie et al., 
2005; Blomgran et al., 2011). 
An important activity of neutrophils is a secretion of inflammatory mediators and their 
inhibitors. The list includes proinflammatory cytokines IL-1 and TNF-, the major 
neutrophil attracting chemokines IL-8 and CXCL2, growth factors GM-CSF and VEGF, 
several metalloproteinases,  IL-1Ra, TGF-┚ (McColl et al., 1992; Cassatella, 1995; Riedel & 
Kaufamm, 1997; Petrofsky et al., 1999; Scapini et al., 2000; Matzer et al., 2001; Sawant & 
McMurray, 2007; Lyadova et al., 2010). The secretion is not high, but when neutrophils 
accumulate in high numbers, it may represent an important source of inflammatory factors. 
Interestingly, many neutrophils contain intracellular IFN-. This was shown during Mtb 
infection (our unpublished observations) and also in other models (Terri & Beaman, 2002). 
Neutrophils not only produce proinflammatory cytokines by themselves, but also stimulate 
proinflammatory activity of macrophages (Persson et al., 2008).  
An important issue is that factors produced by neutrophils are the major positive 
regulators of their activity: TNF- and IL-1 enhance neutrophils’ migration, 
degranulation, oxidative and secretory activities; IL-8 and CXCL2 are the major 
neutrophil-attracting chemokines; IFN- promotes secretory activity; metalloproteinases 
degrade extracellular matrix facilitating cell migration within the inflamed tissue. Thus, 
neutrophilic inflammation is under an autocrine regulation. The major inhibitors of 
cytokine production by neutrophils are IL-10, IL-4, and IL-13 (Witko-Sarsat et al., 2000), 
but they are poorly produced during TB. 
Neutrophils release bactericidal molecules and enzymes not only into the phagosome, but 
also into the extracellular milieu. This allows killing extracellular microbes, but on the other 
part is detrimental: serine proteinases degrade almost all components of extracellular matrix 
and a variety of plasma proteins; collagenase (MMP8) and gelatinase (MMP9) cleave 
different types of collagen; ROI and chlorinated oxidants inactivate inhibitors of proteinases, 
activate metalloproteinases and may mediate direct cytotoxic effect (Weiss, 1989; Witko-
Sarsat et al., 2000) 
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The only way to resolve neutrophilic inflammation is to clear the infection: in this case 
emigration of new neutrophils stops; neutrophils that had migrated to the inflamed sites 
undergo apoptosis and are phagocytosed by macrophages. During chronic infections, 
neutrophilic inflammation becomes uncontrolled. 
5.2 Neutrophils during Mtb infection 
5.2.1 Antimycobacterial activity of neutrophils and TB prevention 
Neutrophils are among the first cells that migrate to the focus of lung Mtb infection, and 
they progressively accumulate at the infectious site during the chronic stage of disease. 
Human and mouse neutrophils efficiently phagocyte mycobacteria (Kisich et al., 2002; 
Eruslanov et al., 2005), but their capacity to kill mycobacteria is disputable.  
Denis and Andersen reported that human neutrophils stimulated with IFN- failed to kill 
Mtb (Denis & Andersen, 1991). In line with this, in our previous studies mouse neutrophils 
displayed low antimycobacterial activity that could not be enhanced by the addition of 
exogenous IFN- (Eruslanov et al., 2005). In a recent study by Eum and coauthors (Eum et 
al., 2010), neutrophils present in the sputum and BAL fluids of patients with active 
pulmonary TB contained Mtb that exhibited signs of replication. Based on these 
observations, it is concluded that neutrophils have poor antimycobacterial activity and 
during TB act by hiding Mtb from macrophages and permitting Mtb replication (Eruslanov 
et al., 2005; Eum et al., 2010).  
In other studies, neutrophils were shown to kill Mtb. The effect was mediated by -
defensins, LL37 and lipocalin and promoted by TNF- (Kisich et al., 2002). Of note, IFN- 
did not enhance killing, which may explain a failure to detect neutrophil-mediated Mtb 
killing in the studies described above (Denis & Andersen, 1991; Eruslanov et al., 2005). 
Recently, an association between low plasma levels of HNP1-3 and the development of 
multi-drug resistant TB has been demonstrated (Zhu et al., 2011), supporting the 
involvement of neutrophils in TB protection. In line with this, it has been demonstrated that 
black African participants (known to have a relatively high susceptibility to TB) have lower 
counts of neutrophils and lower concentrations of circulating HNP1–3 and lipocalin 2 than 
white participants; in TB contacts, the counts of peripheral blood neutrophils inversely 
correlated with risk of TB development (Martineau et al., 2007). Thus, multiple studies 
suggest a role for neutrophils in TB prevention. 
5.2.2 Neutrophils and TB progression 
In contrast to early stages of Mtb infection, at which neutrophils are not numerous and may 
contribute to Mtb control, during active disease neutrophils become more abundant and 
may cause severe pathology. In humans, high numbers of neutrophils in BAL fluids have 
been associated with disease activity and lung tissue cavitation (Barry et al., 2009; 
Sutherland et al., 2009). In mice, neutrophils (Gr-1-positive cells) accumulate abundantly in 
the lungs of susceptible mice (e.g., I/St, DBA/2) but are less numerous in resistant mice 
(Eruslanov et al., 2005; Keller et al., 2006). It is believed that neutrophils contribute to disease 
progression by amplifying local inflammatory reactions and mediating tissue injury.  
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An important question is whether the propensity to develop extensive neutrophilic 
inflammation is a primary cause of host susceptibility to the infection. In some studies, 
granulocytes from susceptible mice were shown to have intrinsically high capacity for 
migration in response to inflammatory stimuli (Keller et al., 2006). However, neutrophilic 
infiltration is a characteristic future of severe TB in hosts of different genetic backgrounds, 
e.g., in DBA/2, C3H, I/St, 129Sv mice. It is unlikely that initial mechanisms of TB 
susceptibility operating in these mice are identical. Rather, at early stages of infection the 
disease is driven via different pathways. Such pathways may include defects in host 
ability to restrict Mtb growth, intrinsic hyperreactivity of host macrophages to Mtb 
derived ligands resulting in overproduction of neutrophil-activating factors, or high 
reactivity of neutrophils to inflammatory stimuli. Ultimately, different pathways converge 
to induce uncontrolled inflammation, characterized by high local production of 
proinflammatory factors and extensive neutrophilic infiltration. These inflammatory 
reactions become a hallmark and an important pathogenic mechanism of TB progression.  
It would be interesting to know whether “inflammatory” neutrophils (i.e., neutrophils 
residing in highly inflammatory conditions) retain their antibacterial activity and can, at 
least in part, mediate Mtb control, or whether at this stage of disease they exhibit only 
inflammatory functions.  
5.2.3 Neutrophil depletion experiments 
To directly address a role for neutrophils in anti-TB defense, several groups examined how 
neutralization of granulocytes affected Mtb infection in mice.  
Pedrosa and colleagues (Pedrosa et al., 2000) found that depletion of neutrophils from TB-
resistant BALB/c mice during the first week of Mtb infection worsened disease and 
increased bacillary growth. The effect was due to a decreased production of IFN- and NO, 
i.e. was mediated indirectly. Depletion of neutrophils at late stages of the infection did not 
have a significant effect on the growth of Mtb in the lungs. Appelberg and coauthors 
(Appelberg et al., 1995) performed studies in B6 and beige mice. Beige mice bear mutation 
that affects function of leukocytes, including granulocytes, and renders mice susceptible to 
M. avium. Transfusion of beige mice with B6 granulocytes at the early stage of infection 
increased host resistance. In contrast, depletion of neutrophils from B6 mice increased host 
susceptibility. Seiler and coauthors (Seiler et al., 2003) reported that early depletion of 
granulocytes from B6 mice did not affect host survival or Mtb burden, but impaired 
granuloma formation.  
In the study by Ehlers’ group (Keller et al., 2006), depletion of granulocytes from TB 
resistant B6 or BALB/c mice did not affect the course of Mtb infection. In contrast, in TB-
susceptible DBA/2 mice depletion of granulocytes had beneficial effect and prolonged mice 
survival. In CARD9-/- mice, depletion of neutrophils on days 8-14 post-challenge 
significantly prolonged mice survival. The effect was due to a reduced inflammation, and 
was not associated with changes in bacterial burdens (Dorhoi et al., 2010).  
The results of these studies are usually interpreted as contradictory. In fact, they are 
compatible and can be explained by (i) the differential role for neutrophils at early and late 
stages of Mtb infection; (ii) different strength of neutrophilic inflammation in genetically 
different hosts. We suppose that at the early stage of the infection, when neutrophils are not 
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numerous and neutrophil-activating proinflammatory cytokines are not abundant, 
neutrophils contribute to Mtb control. At the late stage of the disease, the action of 
neutrophils depends on the strength of local inflammation: if neutrophils accumulate in 
high numbers and are in highly inflammatory milieu (conditions usually observed in TB-
susceptible mice), they become deleterious. Thus, depletion of neutrophils reduced Mtb 
control and worsened disease in resistant mice, but dampened inflammation and 
ameliorated disease course in susceptible mice.  
5.2.4 Not all Gr-1/Ly-6G-positive cells accumulating in the lungs at the advanced 
stage of Mtb infection are neutrophils 
To address a role for granulocytes in TB progression, we have recently used our F2 model of 
Mtb infection (Lyadova et al., 2010). In this model, (A/SnxI/St)F2 mice challenged with Mtb 
display different rates of TB progression. We examined the accumulation of cells expressing 
Gr-1 marker (marker expressed by granulocytes and to a less extent – by monocytes) and 
Ly-6G molecules (molecules thought to be expressed exclusively by granulocytes) in the 
lungs of F2 mice at advanced stage of disease (day 24 post-infection). We found that the 
population of Gr-1-positive cells infiltrating Mtb-infected lungs, was not homogeneous, and 
consisted of two different subsets, Gr-1hi and Gr-1dim. Similarly, Ly-6G-positive cells 
contained Ly-6Ghi and Ly-6Glow subsets. In mice with slowly progressing TB all Gr-1/Ly-
6G-positive cells were Gr-1hi/Ly-6Ghi. In contrast, in mice with severe infection a vast 
majority of Gr-1/Ly-6G-positive cells were Gr-1dim/Ly-6Gdim, whereas Gr-1hi/Ly-6Ghi cells 
were almost undetectable. Further analysis showed that Gr-1hi/Ly-6Ghi cells were 
granulocytes: they expressed F4-80negCD11bhi phenotype and had segmented nuclei. Gr-
1dim/Ly-6Gdim cells exhibited characteristics of immature myeloid cells: they had F4-
80lowCD11bhi phenotype that could be attributed nor to mature granulocytes nor to 
monocytes. Analysis of nuclear morphology showed that these cells had un-segmented or 
low-segmented nuclei. At advanced stage of Mtb infection, Ly-6Gdim cells appeared and 
accumulated not only in the lungs, but also in the bone marrow (Tsiganov E.N., Lyadova 
I.V., manuscript in preparation), suggesting that hematopoiesis was altered in mice with  
progressing TB and that the accumulation of Gr-1dim/Ly-6Gdim cells in the lungs was a result 
of this alteration.  
In connection with these data, two points should be discussed.   
First, Gr-1 and even Ly-6G expressing cells accumulating in the lungs of Mtb-infected mice 
do not necessarily represent mature neutrophils. Experimental studies in which neutrophils 
were identified based on their Gr-1/Ly-6G-positivity should be revised to take into account 
the level of Gr-1/Ly-6G expression. Similarly, several studies identified neutrophils based 
on the expression of myeloperoxidase. This enzyme is, indeed, synthesized be granulocytes, 
but also - by their myeloid precursors.  
Second, our data suggest that severe TB is accompanied by hematopoietic shifts that result 
in a progressive accumulation of immature myeloid cells and gradual disappearance of 
mature neutrophils from Mtb-infected lungs. It will be interesting to examine, whether the 
substitution of neutrophils by immature cells may underlie inability of “neutrophils” to 
control Mtb infection at the advanced stages of TB disease.  
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6. Conclusion  
Inflammation plays a dual role in host immune response to mycobacteria. On the one part, it 
is prerequisite for successful pathogen elimination. On the other part, it mediates tissue 
injury and disease progression. At the onset of the infection, inflammatory reactions are 
largely protective; during active disease, the deleterious effect of inflammation prevails,   
making inflammation a paramount pathogenic factor of TB progression.  
Irrespectively on genetic factors and molecular pathways that have lead to severe TB (that 
are different in genetically different hosts), pathogenetic mechanisms operating during 
advanced stage of disease are common. They include overproduction of proinflammatory 
factors and excessive infiltration of the lung tissue with neutrophils (or their precursors). A 
positive feedback loop between these reactions exists (proinflammatory factors promote 
neutrophilic inflammation; neutrophils produce proinflammatory factors; both induce tissue 
injury, Mtb dissemination, and another round of inflammation) making the regulation of the 
ongoing inflammation difficult. An additional and a new component of TB progression is 
alteration of host hematopoiesis that results in the generation of immature myeloid cells, 
their emigration and prominent accumulation in the periphery. The role for these cells in TB 
progression is yet to be determined.  
The fact that mechanisms mediating TB progression are common has an important practical 
outcome: there is no need to search for exact cause that has driven severe disease in each 
individual; it might be possible to slow down disease progression by interfering with any of 
the pathways involved in hyperinflammatory response. With this respect, co-treatment of 
host with anti-Mtb and anti-inflammatory drugs opens new perspectives for efficient TB 
therapy (Koo et al., 2011).  
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